Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Nita L. Seibel(National Cancer Institute), Paul S. Gaynon(University of Southern California), Cynthia DeLaat(Cincinnati Children's Hospital Medical Center), Lawrence J. Ettinger(Saint Peter's University Hospital), Charles M. Rubin(Comer Children's Hospital), Peter G. Steinherz(Memorial Sloan Kettering Cancer Center), Cheryl Edens(Vanderbilt University), Caroline A. Hastings(UCSF Benioff Children's Hospital), Janet Franklin(Children's Hospital of Los Angeles), Leonard A. Mattano, David R. Freyer(University of Southern California), Mei La(Arcadia), Nyla A. Heerema(The Ohio State University), Allan F. Pyesmany(Izaak Walton Killam Health Centre), James B. Nachman(University of Chicago), Torrey L. Mitchell(Blank Children's Hospital), Harland N. Sather(Children's Oncology Group), Kathy Bertolone(Kosair Children's Hospital)
Cited by 310
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914